Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

19%

3 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed trials have results

Key Signals

2 recruiting6 with results

Enrollment Performance

Analytics

Phase 2

9(56.3%)

Phase 1

4(25.0%)

Phase 3

2(12.5%)

Phase 4

1(6.3%)

16Total

Phase 2(9)

Phase 1(4)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT06053814Phase 1Active Not Recruiting

NS-050/NCNP-03 in Boys With DMD (Meteor50)

Role: collaborator

NCT06046222Phase 2Recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

Role: collaborator

NCT05996003Phase 2Recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Role: collaborator

NCT07441200Phase 2Not Yet Recruiting

Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Role: collaborator

NCT07441278Phase 2Not Yet Recruiting

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Role: collaborator

NCT05135663Phase 2Active Not Recruiting

Extension Study of NS-089/NCNP-02 in DMD

Role: lead

NCT04854096Phase 2Terminated

Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

Role: collaborator

NCT04060199Phase 3Completed

Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)

Role: collaborator

NCT06670898Phase 1Completed

A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects

Role: lead

NCT04956289Phase 2Completed

Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)

Role: collaborator

NCT04768062Phase 3Active Not Recruiting

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Role: collaborator

NCT03167255Phase 2Completed

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Role: collaborator

NCT04129294Phase 1Completed

Exploratory Study of NS-089/NCNP-02 in DMD

Role: collaborator

NCT02740972Phase 2Completed

Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Role: collaborator

NCT02081625Phase 1Completed

Exploratory Study of NS-065/NCNP-01 in DMD

Role: collaborator

NCT02431754Phase 4Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Role: collaborator

All 16 trials loaded